293 related articles for article (PubMed ID: 20583396)
1. Sildenafil and beraprost combination therapy in patients with pulmonary hypertension undergoing valvular heart surgery.
Kim SY; Shim JK; Shim YH; Hong SW; Choi KH; Kwak YL
J Heart Valve Dis; 2010 May; 19(3):333-40. PubMed ID: 20583396
[TBL] [Abstract][Full Text] [Related]
2. Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics.
Matamis D; Pampori S; Papathanasiou A; Papakonstantinou P; Tsagourias M; Galiatsou E; Koulouras V; Nakos G
Circ Heart Fail; 2012 Jan; 5(1):47-53. PubMed ID: 22057829
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery.
Shim JK; Choi YS; Oh YJ; Kim DH; Hong YW; Kwak YL
J Thorac Cardiovasc Surg; 2006 Dec; 132(6):1420-5. PubMed ID: 17140970
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
7. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure.
Maruszewski M; Zakliczyński M; Przybylski R; Kucewicz-Czech E; Zembala M
Transplant Proc; 2007 Nov; 39(9):2850-2. PubMed ID: 18021999
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension.
Michelakis ED; Tymchak W; Noga M; Webster L; Wu XC; Lien D; Wang SH; Modry D; Archer SL
Circulation; 2003 Oct; 108(17):2066-9. PubMed ID: 14568893
[TBL] [Abstract][Full Text] [Related]
9. Scheduled perioperative switch from oral sildenafil to intravenous epoprostenol in a patient with Eisenmenger syndrome undergoing a sigmoidectomy.
Moriyama K; Uzawa K; Iijima T; Kotani M; Moriyama K; Ohashi Y; Satoh T; Yorozu T
J Clin Anesth; 2012 Sep; 24(6):487-9. PubMed ID: 22762976
[TBL] [Abstract][Full Text] [Related]
10. Sarcoidosis-associated pulmonary hypertension: acute vasoresponsiveness to inhaled nitric oxide and the relation to long-term effect of sildenafil.
Milman N; Svendsen CB; Iversen M; Videbaek R; Carlsen J
Clin Respir J; 2009 Oct; 3(4):207-13. PubMed ID: 20298406
[TBL] [Abstract][Full Text] [Related]
11. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
12. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
13. Combined use of PDE5 inhibitors and nitrates in the treatment of pulmonary arterial hypertension in patients with heart failure.
Stehlik J; Movsesian MA
J Card Fail; 2009 Feb; 15(1):31-4. PubMed ID: 19181291
[TBL] [Abstract][Full Text] [Related]
14. Does Sildenafil produce a sustained benefit in patients with pulmonary hypertension associated with parenchymal lung and cardiac disease?
Madden BP; Sheth A; Wilde M; Ong YE
Vascul Pharmacol; 2007; 47(2-3):184-8. PubMed ID: 17627899
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
Botha P; Parry G; Dark JH; Macgowan GA
J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
[TBL] [Abstract][Full Text] [Related]
16. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
17. Low-dose oral sildenafil for patients with pulmonary hypertension: a cost-effective solution in countries with limited resources.
Vida VL; Gaitan G; Quezada E; Barnoya J; Castañeda AR
Cardiol Young; 2007 Feb; 17(1):72-7. PubMed ID: 17184573
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
Blanco I; Gimeno E; Munoz PA; Pizarro S; Gistau C; Rodriguez-Roisin R; Roca J; Barberà JA
Am J Respir Crit Care Med; 2010 Feb; 181(3):270-8. PubMed ID: 19875684
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil for pulmonary hypertension.
Lee AJ; Chiao TB; Tsang MP
Ann Pharmacother; 2005 May; 39(5):869-84. PubMed ID: 15827074
[TBL] [Abstract][Full Text] [Related]
20. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA; Voswinckel R; Reichenberger F; Olschewski H; Haredza P; Karadaş B; Schermuly RT; Weissmann N; Seeger W; Grimminger F
J Am Coll Cardiol; 2004 Oct; 44(7):1488-96. PubMed ID: 15464333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
